<?xml version="1.0" encoding="UTF-8"?>
<p>Finally, the reduced MTT was assayed at 545 nm, using a microplate reader utilising wells with untreated cells serving as control
 <xref rid="CIT0027" ref-type="bibr">
  <sup>27</sup>
 </xref>. In the case of the most active compounds (i.e. higher than 50% growth inhibition at 30 µM), the assays were repeated with a set of dilutions, sigmoidal dose–response curves were fitted to the determined data and the IC
 <sub>50</sub> values (the concentration at which the extent of cell proliferation was half that of the untreated control) were calculated by means of GraphPad Prism 4.0 (GraphPad Software, San Diego, CA). All 
 <italic>in vitro</italic> experiments were carried out on two microplates with at least five parallel wells. Stock solutions of the tested substances (10 mM) were prepared in DMSO. The highest DMSO content of the medium (0.3%) did not have any substantial effect on cell proliferation. Cisplatin (Ebewe Pharma GmbH, Unterach, Austria) was used as positive control.
</p>
